Prediction of Chronic Kidney Disease Following Pre-eclampsia: Diagnosis and Early Care

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Pre-eclampsia (PE) is a pregnancy-associated syndrome of variable severity, classically defined by the combination of hypertension and proteinuria in a previously non-hypertensive or proteinuric patient. These symptoms normally resolve within 2-3 months after delivery regardless of the severity of the pre-eclampsia. Regardless of its definition, preeclampsia is associated with an increased risk of obstetric events and, for the mother, an increased risk of developing chronic kidney disease (CKD), hypertension, diabetes and cardiovascular disease in the broad sense. The relationship between preeclampsia and Chronic Kidney Disease is, however, complex and not fully understood. Investigator proposes an interventional study to identify the diagnosis of Chronic Kidney Disease in patients who have developed an episode of Preeclampsia.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Healthy Volunteers: f
View:

• Meeting the preeclampsia criteria or one of its complications (eclampsia, HELLP syndrome) according to the ISSHP 2018 definitions within the last 5 years

• Having signed the informed consent

• Person affiliated to social security

Locations
Other Locations
France
Chu Angers
NOT_YET_RECRUITING
Angers
Centre Hospitalier Du Mans
RECRUITING
Le Mans
Contact Information
Primary
Christelle JADEAU
cjadeau@ch-lemans.fr
+33 2 44 71 07 81
Time Frame
Start Date: 2022-05-30
Estimated Completion Date: 2037-05-30
Participants
Target number of participants: 400
Treatments
Experimental: patient with preeclampsia
Patient meeting the preeclampsia criteria or one of its complications (eclampsia, HELLP syndrome) according to the ISSHP 2018 definitions within the last 5 years
Related Therapeutic Areas
Sponsors
Leads: Centre Hospitalier le Mans

This content was sourced from clinicaltrials.gov